Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial.TROMBOFIB trial

Next Previous
Trial Profile

Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial.TROMBOFIB trial

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Surgical blood loss
  • Focus Therapeutic Use
  • Acronyms TROMBOFIB

    • Most Recent Events

    • 01 Jan 2023 Primary endpoint (Evaluation of the rate of red blood cell packs transfusion during procedure and in the first 24hours after between groups) has not been met according to Results published in the Journal of Thrombosis and Haemostasis.
    • 01 Jan 2023 Results hypothesized that infusions of fibrinogen concentrate to reach an A10(FibTem) value of 11 mm during LT could reduce red blood cell (RBC) and other component and fluid requirements in comparison to standard care published in the Journal of Thrombosis and Haemostasis
    • 08 May 2022 This trial has been completed in Spain, according to European Clinical Trials Database record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top